カタログ
全画像を表示 — 無料登録
Googleで続ける — 無料
またはメールで登録
登録が必要な理由は？ボットからカタログを守るためだけです。メールアドレスは非公開で、共有したり許可なくメールを送ることは一切ありません。それをお約束します！
| 表面の説明 | ログイン して詳細を見る |
|---|---|
| 表面の銘文 | ログイン して詳細を見る |
| 裏面の説明 | The reverse is devoted to the theme of medical innovation. At centre, a vignette shows a researcher in a laboratory coat working at a microscope modelled on the Carl Zeiss Axioplan 2, with a DNA double-helix strand rendered to its right. Below the central vignette runs an electrocardiogram trace, beside which an early insulin bottle is placed, referencing one of Canada's most celebrated medical contributions. At left, the denomination and a mirrored reflection of the holographic strip are visible, while at right the reverse face of the maple leaf-shaped transparent window appears with the denomination below. |
| 裏面の銘文 | 100 Canada INNOVATION MÉDICALE MEDICAL INNOVATION INSULIN INSULINE 100 |
| 署名 | ログイン して詳細を見る |
| 偽造防止技術 | ログイン して詳細を見る |
| 偽造防止の説明 | ログイン して詳細を見る |
| バリエーション | ログイン して詳細を見る |
| コメント |
The 2011 polymer series marked a significant production shift for the Bank of Canada — moving away from cotton-rag paper stock that had defined Canadian currency for over a century. The $100 was the first denomination released in November 2011, ahead of the lower values, a deliberate sequencing choice driven by counterfeiting risk. Early distribution was plagued by complaints that notes stuck together in cold weather and became brittle; the Bank acknowledged the issue and attributed it to handling technique rather than a manufacturing defect, a response that satisfied almost nobody.
Printed by the Canadian Bank Note Company in Ottawa, the series introduced a large transparent window with a laser-etched element — at the time among the more technically demanding security features in North American circulation.